🔴 Cerenome is trading 5.1% down today amid broader market risk-off pressure

Cerenome is trading 5.1% down at $2.67 as broader risk-off conditions pressure equities.

• No new company-specific announcement was identified for September 1, 2026, and CNBC likewise reports no recent company news.
• The Nasdaq is down 0.92%, while geopolitical tensions, higher oil prices, rising Treasury yields, and upcoming U.S. labor and manufacturing data pressure equities.
• Cerenome’s healthcare sector is diverging positively, making global market sentiment the likelier explanation; the latest identifiable catalyst was an August 14 quarterly loss and revenue miss.